Devdiscourse
Development News Edition
Give Feedback
write for Us

UK MHRA approves Lupin Pharma's Goa facility

Pharma major Lupin today said it has received approval from the UK health regulator its Goa facility.


PTI India
Updated: 16-07-2018 12:05 IST
UK MHRA approves Lupin Pharma's Goa facility

Shares of Lupin were trading 2.35 per cent lower at Rs 844.90 on BSE. (Image Credit: Twitter)

Pharma major Lupin today said it has received approval from the UK health regulator its Goa facility.

Lupin in a regulatory filing said, "it has received approval from UK MHRA (United Kingdom's Medicines and Healthcare products Regulatory Agency) for its Goa facility.

The unit was inspected by UK MHRA in March 2018 and there were no critical or major observations cited, it added.

Shares of Lupin were trading 2.35 per cent lower at Rs 844.90 on BSE.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

COUNTRY : India United Kingdom

POST A COMMENT